Skip to main content
logo
Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
3.615
+0.165 (4.78%)
Aug 4, 2026, 10:20 AM EDT - Market open

Ernexa Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.580.07--
Revenue Growth
--755.88%---
Gross Profit
--0.49-0.17--
Operating Income
-12.18-9.32-15.67-21.14-33.22-113.73
Net Income
-18.49-14.1-44.56-21.68-24.6-122.56
Earnings Per Share
-26.20-56.00-1224.00-1531.25--
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.181.881.737.5811.4516.99
Total Debt
0.390.490.6841.841.182.72
Net Cash (Debt)
8.791.391.05-34.2710.2614.26
Net Cash Growth
-33.40%---28.03%-
Net Cash Per Share
21.205.5328.71-2420.06--

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.22-7.02-15.84-20.41-20.98-23.49
Capital Expenditures
--0.04-0.37-0.02-0.3-0.15
Free Cash Flow
-7.22-7.05-16.21-20.43-21.27-23.64
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--83.51%-247.06%--
Operating Margin
---2693.13%-31080.90%--
Pretax Margin
---7647.59%-31869.12%--
Profit Margin
---7652.75%-31864.70%--
FCF Margin
---2784.36%-30039.70%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--25.96143.34--